Patents by Inventor Yaron Goren

Yaron Goren has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11550902
    Abstract: Techniques are described herein that are capable of using security event correlation to describe an authentication process. Multiple events may describe a common (i.e., same) attempt to authenticate the user. For instance, a first event may include a first description of the attempt, a second event may include a second description of the attempt, and a third event may include a third description of the attempt. The first, second, and third events may be correlated based at least in part on the first, second, and third descriptions. The first, second, and third events may be aggregated to provide an aggregated event that includes an aggregation of the first, second, and third descriptions. An authentication report may be generated to include the aggregation of the first, second, and third descriptions to describe the authentication process.
    Type: Grant
    Filed: January 2, 2020
    Date of Patent: January 10, 2023
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Tal Joseph Maor, Mor Rubin, Noa Goren, Yaron Kaner
  • Publication number: 20220267863
    Abstract: Described herein are compositions and methods for the prediction of bladder cancer risk of invasiveness. The compositions are microRNA molecules associated with the prognosis of bladder cancer, as well as various nucleic acid molecules relating thereto or derived therefrom.
    Type: Application
    Filed: May 9, 2022
    Publication date: August 25, 2022
    Inventors: Ofer Nativ, Yaron Goren
  • Publication number: 20200140952
    Abstract: Described herein are compositions and methods for the prediction of bladder cancer risk of invasiveness. The compositions are microRNA molecules associated with the prognosis of bladder cancer, as well as various nucleic acid molecules relating thereto or derived therefrom.
    Type: Application
    Filed: May 3, 2019
    Publication date: May 7, 2020
    Applicant: ROSETTA GENOMICS LTD.
    Inventors: Ofer Nativ, Yaron Goren
  • Publication number: 20190169690
    Abstract: The invention provides a method of diagnosing Alzheimer's disease (AD) in a subject by determining the level of expression of one or more miRNAs molecules associated with AD, as well as various nucleic acid molecules relating thereto or derived thereof.
    Type: Application
    Filed: December 13, 2018
    Publication date: June 6, 2019
    Applicant: ROSETTA GENOMICS LTD.
    Inventor: Yaron Goren
  • Patent number: 9631236
    Abstract: The present invention is based in part on the discovery of a panel of miRs whose levels are increased or decreased in the circulation of chronic systolic HF patients. Accordingly, an extensive panel of miRs was screened in the sera of stable chronic systolic HF patients and the results were compared to an age, gender and ethnically matched control group.
    Type: Grant
    Filed: May 23, 2012
    Date of Patent: April 25, 2017
    Assignees: Rosetta Genomics Ltd., MOR Research Applications Ltd.
    Inventors: Yaron Goren, Ofer Amir
  • Publication number: 20170067106
    Abstract: The invention provides a method of diagnosing Alzheimer's disease (AD) in a subject by determining the level of expression of one or more miRNAs molecules associated with AD, as well as various nucleic acid molecules relating thereto or derived thereof.
    Type: Application
    Filed: April 13, 2016
    Publication date: March 9, 2017
    Inventor: Yaron Goren
  • Publication number: 20160186271
    Abstract: Described herein are compositions and methods for the prediction of bladder cancer risk of invasiveness. The compositions are microRNA molecules associated with the prognosis of bladder cancer, as well as various nucleic acid molecules relating thereto or derived therefrom.
    Type: Application
    Filed: December 21, 2015
    Publication date: June 30, 2016
    Inventors: Ofer Nativ, Yaron Goren
  • Patent number: 9334540
    Abstract: The present invention provides methods and compositions for identifying subjects at risk of developing a complication of pregnancy, such as preeclampsia or preterm labor. The compositions are microRNAs and associated nucleic acids.
    Type: Grant
    Filed: October 25, 2013
    Date of Patent: May 10, 2016
    Assignees: Rosetta Genomics Ltd., MOR Research Applications
    Inventors: Yaron Goren, Shlomit Gilad, Moshe Hod, Yariv Yogev
  • Publication number: 20140206777
    Abstract: The invention provides a method of diagnosing Alzheimer's disease (AD) in a subject by determining the level of expression of one or more miRNAs molecules associated with AD, as well as various nucleic acid molecules relating thereto or derived thereof.
    Type: Application
    Filed: August 14, 2012
    Publication date: July 24, 2014
    Applicant: ROSETTA GENOMICS LTD.
    Inventor: Yaron Goren
  • Publication number: 20140171400
    Abstract: The present invention is based in part on the discovery of a panel of miRs whose levels are increased or decreased in the circulation of chronic systolic HF patients. Accordingly, an extensive panel of miRs was screened in the sera of stable chronic systolic HF patients and the results were compared to an age, gender and ethnically matched control group.
    Type: Application
    Filed: May 23, 2012
    Publication date: June 19, 2014
    Inventors: Yaron Goren, Ofer Amir
  • Publication number: 20140087967
    Abstract: The present invention provides methods and compositions for identifying subjects at risk of developing a complication of pregnancy, such as preeclampsia or preterm labor. The compositions are microRNAs and associated nucleic acids.
    Type: Application
    Filed: October 25, 2013
    Publication date: March 27, 2014
    Applicants: Mor Research Applications, Rosetta Genomics Ltd.
    Inventors: Yaron GOREN, Shlomit Gilad, Moshe Hod, Yariv Yogev
  • Patent number: 8580503
    Abstract: The present invention provides methods and compositions for identifying subjects at risk of developing a complication of pregnancy, such as preeclampsia or preterm labor. The compositions are microRNAs and associated nucleic acids.
    Type: Grant
    Filed: January 26, 2009
    Date of Patent: November 12, 2013
    Assignees: Rosetta Genomics Ltd., Mor Research Applications
    Inventors: Yaron Goren, Shlomit Gilad, Moshe Hod, Yariv Yogev
  • Publication number: 20130123138
    Abstract: Disclosed are compositions and methods for the prognosis of mesothelioma patients after surgical operation. Specifically the disclosure provides microRNA (miRNA) molecules associated with prognosis of mesothelioma, as well as various nucleic acid molecules relating thereto or derived therefrom. The disclosure further provides altered expression of miRNAs that are associated with good or poor prognosis of mesothelioma.
    Type: Application
    Filed: June 9, 2011
    Publication date: May 16, 2013
    Inventors: Harvey Pass, Moshe Hoshen, Yaron Goren
  • Publication number: 20110143959
    Abstract: Described herein are compositions and methods for the prediction of bladder cancer risk of invasiveness. The compositions are microRNA molecules associated with the prognosis of bladder cancer, as well as various nucleic acid molecules relating thereto or derived therefrom.
    Type: Application
    Filed: August 5, 2009
    Publication date: June 16, 2011
    Inventors: Ofer Nativ, Yaron Goren
  • Publication number: 20100291585
    Abstract: The present invention provides methods and compositions for identifying subjects at risk of developing a complication of pregnancy, such as preeclampsia or preterm labor. The compositions are microRNAs and associated nucleic acids.
    Type: Application
    Filed: January 26, 2009
    Publication date: November 18, 2010
    Inventors: Yaron Goren, Shlomit Gilad, Moshe Hod, Yariv Yogev